​

Allarity Therapeutics (ALLR) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Allarity Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$25.00K

Main Segment (Y)

License

Allarity Therapeutics Revenue by Period

Allarity Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--100.00%
2019-12-31$120.00K-91.78%
2018-12-31$1.46M0.09%
2017-12-31$1.46M918.31%
2016-12-31$143.28K-60.45%
2015-12-31$362.29K3532.23%
2014-12-31$9.97K100.00%
2013-12-31--

Allarity Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Allarity Therapeutics Revenue by Quarter

DateRevenueChange
2026-03-31$25.00K-92.19%
2025-12-31$320.00K100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30--100.00%
2020-06-30$1.07M100.00%
2020-03-31--100.00%
2019-12-31$357.58K100.00%
2019-09-30--100.00%
2019-06-30$32.91K-27.72%
2019-03-31$45.53K-426.04%
2018-12-31$-13.96K-101.60%
2018-09-30$873.83K146.38%
2018-06-30$354.67K23.91%
2018-03-31$286.23K32.44%
2017-12-31$216.12K-25.11%
2017-09-30$288.59K-

Allarity Therapeutics generated $25.00K in revenue during Q1 2026, up -92.19% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Allarity Therapeutics Revenue Breakdown

Allarity Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
License$320.00K

Allarity Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 26
License$25.00K

Allarity Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: License (100.00%).

Allarity Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CRISCuris$9.44M-
LEXXLexaria Bioscience$705.92K$20.00K
BCTXBriaCell Therapeutics--
LIXTLixte Biotechnology--
ALLRAllarity Therapeutics-$25.00K
CINGCingulate--
PCSAProcessa Pharmaceuticals--
CLSDClearside Biomedical--

ALLR Revenue FAQ

What is Allarity Therapeutics’s yearly revenue?

Allarity Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ALLR's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Allarity Therapeutics’s quarterly revenue?

Allarity Therapeutics's quarterly revenue for Q1 2026 was $25K, a -92.19% decrease from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $320K, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). ALLR's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Allarity Therapeutics’s revenue growth rate?

Allarity Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Allarity Therapeutics’s revenue streams?

Allarity Therapeutics's revenue streams in c 25 are License

What is Allarity Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Allarity Therapeutics was License. This segment made a revenue of $320K, representing 100.00% of the company's total revenue.